|

Z-endoxifen Clinical Trials

2 actively recruiting trials across 2 locations

▼ -1 trial since June 2026

Also known as: endoxifen

Pipeline

Phase 2: 2

Top Sponsors

  • QuantumLeap Healthcare Collaborative2

Indications

  • Breast Cancer2
  • Cancer2
  • Hormone Receptor Negative Tumor1
  • Hormone Receptor Positive Tumor1
  • Angiosarcoma1

Birmingham, Alabama1 trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

University of Alabama at Birmingham

Phase 2

Berkeley, California1 trial

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Berkeley Outpatient Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.